Systolic Blood Pressure as a Potential Target of Sigma-1 Receptor Agonist Therapy

Journal of Clinical Hypertension - United States
doi 10.1111/jch.13197
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Cardioprotective Effect of the Selective Sigma-1 Receptor Agonist, SA4503

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2014English

Sigma-2 Receptor as Potential Indicator of Stem Cell Differentiation

Molecular Imaging and Biology
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2011English

Metabolic Actions of the Type 1 Cholecystokinin Receptor: Its Potential as a Therapeutic Target

Trends in Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2016English

Clinical Usefulness of the Second Peak of Radial Systolic Blood Pressure for Estimation of Aortic Systolic Blood Pressure

Journal of Human Hypertension
Internal Medicine
2009English

Sigma 1 Receptor Modulators as a New Weapon Against Multiple Sclerosis

BioDiscovery
2017English

A Potent Peptide as Adiponectin Receptor 1 Agonist to Against Fibrosis

Journal of Enzyme Inhibition and Medicinal Chemistry
MedicineDrug DiscoveryPharmacology
2017English

Blood Pressure as a Drug Target: What Should We Be Measuring?

British Journal of Clinical Pharmacology
Pharmacology
2012English

Sp572mean of Pre- And Post-Dialysis Systolic Blood Pressure Is an Independent Predictor of Home Systolic Blood Pressure in Hemodialysis Patients

Nephrology Dialysis Transplantation
MedicineTransplantationNephrology
2015English

HIV-1 Capsid as a Target for Antiviral Therapy

Journal of AIDS & Clinical Research
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy